98%
921
2 minutes
20
Background: Higher center volume has been associated with improved outcomes in solid organ transplantation. However, the impact of center experience on donation after circulatory death (DCD) heart transplantation outcomes remains unclear. This study evaluates the association between cumulative DCD center experience and DCD posttransplant survival.
Methods: The UNOS registry was queried for adult recipients who underwent DCD heart transplantation from 1/1/2019 to 12/31/2023. Recipients were stratified by cumulative DCD center experience into low (≤10), intermediate (11-24), and high (≥25) transplant volume centers. The primary outcome was 1-year posttransplant survival. A restricted cubic spline (RCS) model was used to assess the volume-outcome relationship.
Results: A total of 1,114 DCD heart transplant recipients across 59 centers were included. Low cumulative DCD volume was associated with lower 1-year DCD posttransplant survival compared to high volume centers when controlling for confounders (89.0% vs 92.9%, p=0.025) independent of donation after brain death (DBD) center volume and center-level DBD posttransplant survival. RCS showed decreasing 1-year posttransplant mortality with increasing DCD volume up to 20 DCD cases, beyond which survival gains plateaued. Normothermic regional perfusion (NRP) was associated with similar survival compared to direct procurement and perfusion (DPP) across all center volume categories.
Conclusion: Higher cumulative DCD center experience is associated with improved 1-year DCD posttransplant survival independent of DBD center volume or performance. Survival gains plateau after approximately 20 cumulative DCD cases. These findings highlight the importance of DCD-specific institutional experience and support the expansion of DCD heart transplantation to more centers while maintaining favorable outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.healun.2025.08.015 | DOI Listing |
Am J Health Syst Pharm
September 2025
Department of Pharmacy, Wesley Medical Center, Wichita, KS, USA.
JMIR Res Protoc
September 2025
Center for Alcohol & Addiction Studies, School of Public Health, Brown University, Providence, RI, United States.
Background: Digital media frequently contains positive portrayals of alcohol content, which has been shown to be associated with alcohol-related cognitions and behaviors. Because youth are heavy media consumers and have access to unsupervised, repeat viewing of media content on their personal mobile devices, it is critical to understand the frequency of encountering alcohol content in adolescents' daily lives and how adolescents engage with the content.
Objective: This paper outlines the study protocol for examining adolescents' exposure to alcohol-related content in digital media within their natural environments.
JAMA Intern Med
September 2025
Division of General Internal Medicine, Section of Hospital Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Clin Transl Sci
September 2025
Food and Drug Administration, Silver Spring, Maryland, USA.
Since the first decentralized clinical trial (DCT) was conducted in 2011, there has been an increased usage of DCT due to its benefits of patient-centricity and generalizability of findings. This trend was further expedited by the global COVID-19 pandemic. We identified 23 case studies across various therapeutic areas and grouped them into different categories according to their purposes-by necessity, for operational benefits, to address unique research questions, to validate innovative digital endpoints, or to validate decentralization as a clinical research platform.
View Article and Find Full Text PDFJAMA Netw Open
September 2025
Department of Urology, Center for Health Outcomes Research and Dissemination, University of Washington, Seattle.
Importance: Black individuals have a twofold higher rate of prostate cancer death in the US compared with the average population with prostate cancer. Few guidelines support race-conscious screening practices among at-risk Black individuals.
Objective: To examine structural factors that facilitate or impede access to prostate cancer screening among Black individuals in the US.